Cargando…

Impfungen unter Ofatumumab gelingen

Detalles Bibliográficos
Autor principal: Facharztmagazine, Redaktion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183242/
http://dx.doi.org/10.1007/s15016-023-3126-6
_version_ 1785041913166954496
author Facharztmagazine, Redaktion
author_facet Facharztmagazine, Redaktion
author_sort Facharztmagazine, Redaktion
collection PubMed
description
format Online
Article
Text
id pubmed-10183242
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-101832422023-05-16 Impfungen unter Ofatumumab gelingen Facharztmagazine, Redaktion NeuroTransmitter Pharmaforum Springer Medizin 2023-05-15 2023 /pmc/articles/PMC10183242/ http://dx.doi.org/10.1007/s15016-023-3126-6 Text en © Berufsverband Deutscher Nervenärzte e.V. (BVDN) 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Pharmaforum
Facharztmagazine, Redaktion
Impfungen unter Ofatumumab gelingen
title Impfungen unter Ofatumumab gelingen
title_full Impfungen unter Ofatumumab gelingen
title_fullStr Impfungen unter Ofatumumab gelingen
title_full_unstemmed Impfungen unter Ofatumumab gelingen
title_short Impfungen unter Ofatumumab gelingen
title_sort impfungen unter ofatumumab gelingen
topic Pharmaforum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183242/
http://dx.doi.org/10.1007/s15016-023-3126-6
work_keys_str_mv AT facharztmagazineredaktion impfungenunterofatumumabgelingen